ZOETIS INC

NYSE: ZTS (Zoetis Inc.)

Kemas kini terakhir: 8 jam lalu

120.06

-0.33 (-0.27%)

  • 1H -0.27%
  • 5H -6.33%
  • 1B -0.36%
  • 6B -28.79%
  • Tahun Ke Tarikh -26.17%
  • 1T -31.30%
  • 5T -24.23%
Penutupan Terdahulu 120.39
Buka 122.46
Jumlah Dagangan 125,067
Purata Dagangan (3B) 3,865,741
Modal Pasaran 53,208,608,768
Harga / Pendapatan (P/E TTM) 20.21
Harga / Pendapatan (P/E Ke hadapan) 19.49
Harga / Jualan (P/S) 6.10
Harga / Buku (P/B) 10.46
Julat 52 Minggu
115.25 (-4%) — 181.85 (51%)
Tarikh Pendapatan 4 Nov 2025
Hasil Dividen (DY TTM) 0.83%
Margin Keuntungan 27.12%
Margin Operasi (TTM) 38.11%
EPS Cair (TTM) 5.56
Pertumbuhan Hasil Suku Tahunan (YOY) 1.40%
Pertumbuhan Pendapatan Suku Tahunan (YOY) 5.30%
Jumlah Hutang/Ekuiti (D/E MRQ) 145.63%
Nisbah Semasa (MRQ) 1.74
Aliran Tunai Operasi (OCF TTM) 2.94 B
Aliran Tunai Bebas Leveraj (LFCF TTM) 2.30 B
Pulangan Atas Aset (ROA TTM) 15.11%
Pulangan Atas Ekuiti (ROE TTM) 52.09%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Drug Manufacturers - Specialty & Generic (US) Menaik Bercampur
Drug Manufacturers - Specialty & Generic (Global) Menaik Bercampur
Stok Zoetis Inc. Menurun Menurun

AISkor Stockmoo

1.3
Konsensus Penganalisis 3.0
Aktiviti Orang Dalam NA
Volatiliti Harga 4.0
Purata Bergerak Teknikal 0.0
Osilator Teknikal -2.0
Purata 1.25

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
ZTS 53 B 0.83% 20.21 10.46
TAK 48 B 4.61% 207.43 1.00
HLN 44 B 1.20% 22.18 2.06
RDY 12 B 54.73% 17.71 2.89
TEVA 31 B - 44.08 4.23
BHC 2 B - 23.46 -

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Sektor Healthcare
Industri Drug Manufacturers - Specialty & Generic
Gaya Pelaburan Large Core
% Dimiliki oleh Orang Dalam 0.23%
% Dimiliki oleh Institusi 96.61%

Pemilikan

Nama Tarikh Syer Dipegang
State Farm Mutual Automobile Insurance Co 30 Sep 2025 15,892,903
Polen Capital Management Llc 30 Sep 2025 7,516,911
Unisphere Establishment 30 Sep 2025 4,800,000
Julat 52 Minggu
115.25 (-4%) — 181.85 (51%)
Julat Harga Sasaran
130.00 (8%) — 200.00 (66%)
Tinggi 200.00 (JP Morgan, 66.58%) Beli
Median 167.50 (39.51%)
Rendah 130.00 (Stifel, 8.28%) Pegang
Purata 166.00 (38.26%)
Jumlah 4 Beli, 2 Pegang
Harga Purata @ Panggilan 125.21
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
BTIG 03 Dec 2025 160.00 (33.27%) Beli 122.57
12 Nov 2025 160.00 (33.27%) Beli 121.25
Stifel 18 Nov 2025 130.00 (8.28%) Pegang 118.14
Morgan Stanley 10 Nov 2025 175.00 (45.76%) Beli 119.79
JP Morgan 05 Nov 2025 200.00 (66.58%) Beli 120.49
UBS 05 Nov 2025 141.00 (17.44%) Pegang 120.49
20 Oct 2025 158.00 (31.60%) Pegang 145.06
Argus Research 09 Sep 2025 190.00 (58.25%) Beli 149.79

Tiada data dalam julat masa ini.

  • 3M
Tarikh Jenis Butiran
05 Dec 2025 Pengumuman Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats
02 Dec 2025 Pengumuman Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast
26 Nov 2025 Pengumuman Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
20 Nov 2025 Pengumuman Zoetis to Participate in the Piper Sandler 37th Annual Healthcare Conference
19 Nov 2025 Pengumuman Zoetis to Host Innovation Webcast
04 Nov 2025 Pengumuman Zoetis Announces Third Quarter 2025 Results
03 Nov 2025 Pengumuman Zoetis Announces Retirement of Rob Polzer at the End of 2025 and the Appointment of Kevin Esch as President of Research & Development for World Leader in Animal Health Beginning in 2026
29 Oct 2025 Pengumuman Zoetis Receives European Commission Marketing Authorization for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
28 Oct 2025 Pengumuman Zoetis Appoints Stephanie Tilenius to its Board of Directors
15 Oct 2025 Pengumuman Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs
10 Oct 2025 Pengumuman Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs
09 Oct 2025 Pengumuman Zoetis Declares Fourth Quarter 2025 Dividend
30 Sep 2025 Pengumuman Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle
23 Sep 2025 Pengumuman Zoetis to Host Webcast and Conference Call on Third Quarter 2025 Financial Results
12 Sep 2025 Pengumuman Zoetis Receives Positive Opinion from CVMP for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
Papar semua
Hasil Dividen (DY TTM) 0.83%
Purata Hasil Dividen 5T 0.72%
Nisbah Pembayaran 32.24%
Jangkaan Pembayaran Dividen Seterusnya Jun 2026
Tarikh EX Tarikh Pengumuman Tarikh Pembayaran Perincian
21 Apr 2025 06 Feb 2025 03 Jun 2025 0.5 Tunai
21 Jan 2025 12 Dec 2024 04 Mar 2025 0.5 Tunai
31 Oct 2024 10 Oct 2024 03 Dec 2024 0.432 Tunai
18 Jul 2024 22 May 2024 04 Sep 2024 0.432 Tunai
18 Apr 2024 06 Feb 2024 04 Jun 2024 0.432 Tunai
18 Jan 2024 07 Dec 2023 01 Mar 2024 0.432 Tunai
31 Oct 2023 12 Oct 2023 01 Dec 2023 0.375 Tunai
20 Jul 2023 11 May 2023 01 Sep 2023 0.375 Tunai
20 Apr 2023 08 Feb 2023 01 Jun 2023 0.375 Tunai
19 Jan 2023 08 Dec 2022 01 Mar 2023 0.375 Tunai
31 Oct 2022 13 Oct 2022 01 Dec 2022 0.325 Tunai
20 Jul 2022 19 May 2022 01 Sep 2022 0.325 Tunai
20 Apr 2022 08 Feb 2022 01 Jun 2022 0.325 Tunai
19 Jan 2022 07 Dec 2021 01 Mar 2022 0.325 Tunai
28 Oct 2021 14 Oct 2021 01 Dec 2021 0.25 Tunai
20 Jul 2021 20 May 2021 01 Sep 2021 0.25 Tunai
20 Apr 2021 10 Feb 2021 01 Jun 2021 0.25 Tunai
19 Jan 2021 09 Dec 2020 01 Mar 2021 0.25 Tunai
20 Oct 2020 07 Oct 2020 01 Dec 2020 0.2 Tunai
16 Jul 2020 20 May 2020 01 Sep 2020 0.2 Tunai
16 Apr 2020 11 Feb 2020 01 Jun 2020 0.2 Tunai
16 Jan 2020 12 Dec 2019 03 Mar 2020 0.2 Tunai
21 Oct 2019 04 Oct 2019 02 Dec 2019 0.164 Tunai
18 Jul 2019 16 May 2019 03 Sep 2019 0.164 Tunai
17 Apr 2019 13 Feb 2019 03 Jun 2019 0.164 Tunai
17 Jan 2019 13 Dec 2018 01 Mar 2019 0.164 Tunai
19 Nov 2018 11 Oct 2018 03 Dec 2018 0.126 Tunai
19 Jul 2018 16 May 2018 04 Sep 2018 0.126 Tunai
19 Apr 2018 13 Feb 2018 01 Jun 2018 0.126 Tunai
18 Jan 2018 11 Dec 2017 01 Mar 2018 0.126 Tunai
08 Nov 2017 05 Oct 2017 01 Dec 2017 0.105 Tunai
13 Jun 2017 11 May 2017 01 Sep 2017 0.105 Tunai
04 Apr 2017 14 Feb 2017 01 Jun 2017 0.105 Tunai
18 Jan 2017 06 Dec 2016 01 Mar 2017 0.105 Tunai
01 Nov 2016 06 Oct 2016 01 Dec 2016 0.095 Tunai
28 Jun 2016 12 May 2016 30 Aug 2016 0.095 Tunai
05 Apr 2016 19 Feb 2016 01 Jun 2016 0.095 Tunai
19 Jan 2016 16 Dec 2015 01 Mar 2016 0.095 Tunai
03 Nov 2015 01 Oct 2015 01 Dec 2015 0.083 Tunai
11 Aug 2015 21 Jul 2015 01 Sep 2015 0.083 Tunai
07 Apr 2015 27 Feb 2015 02 Jun 2015 0.083 Tunai
20 Jan 2015 17 Dec 2014 03 Mar 2015 0.083 Tunai
03 Nov 2014 02 Oct 2014 02 Dec 2014 0.072 Tunai
18 Aug 2014 31 Jul 2014 02 Sep 2014 0.072 Tunai
23 Apr 2014 26 Mar 2014 02 Jun 2014 0.072 Tunai
28 Jan 2014 19 Dec 2013 04 Mar 2014 0.072 Tunai
30 Oct 2013 12 Sep 2013 02 Dec 2013 0.065 Tunai
30 Jul 2013 20 Jun 2013 02 Sep 2013 0.065 Tunai
29 Apr 2013 28 Mar 2013 06 Jun 2013 0.065 Tunai
Papar semua

Hasil Dividen Tahunan

Tahun Dividen Tahunan ($) Kekerapan/Tahun Hasil %
2025 1.00 2 0.83
2024 1.73 4 1.06
2023 1.50 4 0.76
2022 1.30 4 0.89
2021 1.00 4 0.41
2020 0.800 4 0.48
2019 0.656 4 0.50
2018 0.504 4 0.59
2017 0.420 4 0.58
2016 0.380 4 0.71
2015 0.332 4 0.69
2014 0.288 4 0.67
2013 0.195 3 0.60
Papar semua

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda